St.Shine Optical Co Ltd (1565) - Net Assets
Based on the latest financial reports, St.Shine Optical Co Ltd (1565) has net assets worth NT$6.55 Billion TWD (≈ $206.39 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$7.81 Billion ≈ $245.96 Million USD) and total liabilities (NT$1.26 Billion ≈ $39.57 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 1565 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$6.55 Billion |
| % of Total Assets | 83.91% |
| Annual Growth Rate | 12.08% |
| 5-Year Change | 9.71% |
| 10-Year Change | 26.53% |
| Growth Volatility | 12.22 |
St.Shine Optical Co Ltd - Net Assets Trend (2002–2025)
This chart illustrates how St.Shine Optical Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore St.Shine Optical Co Ltd assets under control for the complete picture of this company's asset base.
Annual Net Assets for St.Shine Optical Co Ltd (2002–2025)
The table below shows the annual net assets of St.Shine Optical Co Ltd from 2002 to 2025. For live valuation and market cap data, see how much is St.Shine Optical Co Ltd worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | NT$6.55 Billion ≈ $206.39 Million |
-0.11% |
| 2024-12-31 | NT$6.56 Billion ≈ $206.61 Million |
+6.87% |
| 2023-12-31 | NT$6.14 Billion ≈ $193.32 Million |
-2.10% |
| 2022-12-31 | NT$6.27 Billion ≈ $197.47 Million |
+4.97% |
| 2021-12-31 | NT$5.97 Billion ≈ $188.13 Million |
+6.14% |
| 2020-12-31 | NT$5.63 Billion ≈ $177.25 Million |
-2.38% |
| 2019-12-31 | NT$5.76 Billion ≈ $181.58 Million |
-0.73% |
| 2018-12-31 | NT$5.81 Billion ≈ $182.91 Million |
+7.68% |
| 2017-12-31 | NT$5.39 Billion ≈ $169.87 Million |
+4.14% |
| 2016-12-31 | NT$5.18 Billion ≈ $163.12 Million |
+12.70% |
| 2015-12-31 | NT$4.59 Billion ≈ $144.73 Million |
+5.93% |
| 2014-12-31 | NT$4.34 Billion ≈ $136.62 Million |
+11.62% |
| 2013-12-31 | NT$3.89 Billion ≈ $122.41 Million |
+19.93% |
| 2012-12-31 | NT$3.24 Billion ≈ $102.06 Million |
+15.00% |
| 2011-12-31 | NT$2.82 Billion ≈ $88.75 Million |
+14.17% |
| 2010-12-31 | NT$2.47 Billion ≈ $77.74 Million |
+16.14% |
| 2009-12-31 | NT$2.12 Billion ≈ $66.93 Million |
+11.65% |
| 2008-12-31 | NT$1.90 Billion ≈ $59.95 Million |
+7.45% |
| 2007-12-31 | NT$1.77 Billion ≈ $55.79 Million |
+50.34% |
| 2006-12-31 | NT$1.18 Billion ≈ $37.11 Million |
+21.84% |
| 2005-12-31 | NT$966.82 Million ≈ $30.46 Million |
+34.63% |
| 2004-12-31 | NT$718.13 Million ≈ $22.63 Million |
+17.19% |
| 2003-12-31 | NT$612.78 Million ≈ $19.31 Million |
+28.75% |
| 2002-12-31 | NT$475.95 Million ≈ $14.99 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to St.Shine Optical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4634.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$3.43 Billion | 52.34% |
| Other Components | NT$3.12 Billion | 47.66% |
| Total Equity | NT$6.55 Billion | 100.00% |
St.Shine Optical Co Ltd Competitors by Market Cap
The table below lists competitors of St.Shine Optical Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Castles Technology Co Ltd
TW:5258
|
$164.50 Million |
|
Molecular Partners AG ADR
NASDAQ:MOLN
|
$164.56 Million |
|
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT
|
$164.56 Million |
|
Capitan Mining Inc
V:CAPT
|
$164.56 Million |
|
Finance of America Companies Inc
NYSE:FOA
|
$164.30 Million |
|
Endava Ltd
NYSE:DAVA
|
$164.29 Million |
|
Eltel AB
ST:ELTEL
|
$164.29 Million |
|
Novonix Ltd
AU:NVX
|
$164.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in St.Shine Optical Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,557,910,000 to 6,550,903,000, a change of -7,007,000 (-0.1%).
- Net income of 455,031,000 contributed positively to equity growth.
- Dividend payments of 478,957,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$455.03 Million | +6.95% |
| Dividends Paid | NT$478.96 Million | -7.31% |
| Other Changes | NT$16.92 Million | +0.26% |
| Total Change | NT$- | -0.11% |
Book Value vs Market Value Analysis
This analysis compares St.Shine Optical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.80x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.97x to 0.80x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | NT$106.94 | NT$103.50 | x |
| 2018-12-31 | NT$115.16 | NT$103.50 | x |
| 2019-12-31 | NT$113.57 | NT$103.50 | x |
| 2020-12-31 | NT$110.80 | NT$103.50 | x |
| 2021-12-31 | NT$117.62 | NT$103.50 | x |
| 2022-12-31 | NT$123.31 | NT$103.50 | x |
| 2023-12-31 | NT$120.68 | NT$103.50 | x |
| 2024-12-31 | NT$130.07 | NT$103.50 | x |
| 2025-12-31 | NT$129.94 | NT$103.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently St.Shine Optical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.95%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.05%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 1.19x
- Recent ROE (6.95%) is below the historical average (25.17%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 12.30% | 16.36% | 0.56x | 1.35x | NT$10.96 Million |
| 2003 | 17.93% | 19.55% | 0.69x | 1.32x | NT$48.58 Million |
| 2004 | 23.07% | 20.40% | 0.80x | 1.41x | NT$93.84 Million |
| 2005 | 24.11% | 21.37% | 0.80x | 1.40x | NT$136.42 Million |
| 2006 | 30.70% | 22.02% | 0.85x | 1.64x | NT$243.83 Million |
| 2007 | 30.05% | 28.93% | 0.72x | 1.45x | NT$355.02 Million |
| 2008 | 29.52% | 25.85% | 0.79x | 1.44x | NT$371.47 Million |
| 2009 | 29.38% | 26.09% | 0.79x | 1.43x | NT$411.71 Million |
| 2010 | 35.35% | 28.14% | 0.86x | 1.46x | NT$625.55 Million |
| 2011 | 37.87% | 30.84% | 0.88x | 1.39x | NT$785.08 Million |
| 2012 | 37.16% | 28.88% | 0.79x | 1.62x | NT$880.00 Million |
| 2013 | 41.14% | 30.60% | 0.84x | 1.59x | NT$1.21 Billion |
| 2014 | 36.27% | 29.07% | 0.84x | 1.48x | NT$1.14 Billion |
| 2015 | 31.69% | 24.85% | 0.89x | 1.43x | NT$996.60 Million |
| 2016 | 34.34% | 27.52% | 0.88x | 1.42x | NT$1.26 Billion |
| 2017 | 29.48% | 24.76% | 0.75x | 1.60x | NT$1.05 Billion |
| 2018 | 28.72% | 24.98% | 0.76x | 1.51x | NT$1.09 Billion |
| 2019 | 22.33% | 20.28% | 0.75x | 1.46x | NT$710.89 Million |
| 2020 | 13.24% | 14.88% | 0.62x | 1.43x | NT$182.51 Million |
| 2021 | 15.87% | 17.55% | 0.63x | 1.44x | NT$350.64 Million |
| 2022 | 16.26% | 20.37% | 0.60x | 1.32x | NT$392.28 Million |
| 2023 | 8.90% | 12.43% | 0.57x | 1.26x | NT$-67.65 Million |
| 2024 | 11.40% | 16.42% | 0.56x | 1.24x | NT$91.51 Million |
| 2025 | 6.95% | 11.05% | 0.53x | 1.19x | NT$-200.06 Million |
Industry Comparison
This section compares St.Shine Optical Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,726,890,556
- Average return on equity (ROE) among peers: 7.78%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| St.Shine Optical Co Ltd (1565) | NT$6.55 Billion | 12.30% | 0.19x | $164.40 Million |
| Maxigen Biotech Inc (1783) | $369.25 Million | -9.77% | 0.32x | $109.91 Million |
| SciVision Biotech Inc (1786) | $363.70 Million | 14.07% | 0.11x | $135.56 Million |
| Bioteque (4107) | $2.80 Billion | 15.38% | 0.38x | $252.17 Million |
| Chi Sheng Chemical (4111) | $1.05 Billion | 4.04% | 0.44x | $55.51 Million |
| BenQ Medical Technology (4116) | $1.09 Billion | 6.10% | 0.54x | $56.09 Million |
| Pacific Hospital Supply Co Ltd (4126) | $2.71 Billion | 14.28% | 0.40x | $181.84 Million |
| Bionime Corp (4737) | $2.54 Billion | 3.89% | 0.80x | $151.21 Million |
| Vizionfocus Inc. (4771) | $2.02 Billion | 15.48% | 0.59x | $347.59 Million |
| Formosa Optical Technology Co Ltd (5312) | $2.60 Billion | 6.55% | 1.44x | $183.92 Million |
About St.Shine Optical Co Ltd
St.Shine Optical Co.,Ltd., together with its subsidiaries, manufactures, sells, and trades contact lenses, optical lenses, and related products in Asia, Europe, America, and Taiwan. The company's product portfolio includes daily disposable, frequent replacement, color, and silicone hydrogel soft contact lens, as well as cast-molded soft contact lenses. It offers its products under the Ticon brand… Read more